World
Acquisition is expected to complement a key segment of Merck’s Semiconductor Solutions portfolio With the addition of around 100 new employees as ...
January 03, 2023 | News
Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma Complements Existing...
January 03, 2023 | News
Collaboration complements Merck’s internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist ADCs for up to...
December 23, 2022 | News
Together, Versalus Health and CorroHealth enable transformative healthcare analytics for the full revenue cycle Versalus Heath's cli...
December 14, 2022 | News
Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced an exploratory research collaboration to create antibody-drug con...
December 14, 2022 | News
The dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023. Lilly unites caring with ...
December 13, 2022 | News
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data for it...
December 12, 2022 | News
New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches for several ...
December 12, 2022 | News
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first co...
December 09, 2022 | News
Bivalent vaccine authorized as third 3-µg dose in the three-dose primary series Consistent COVID-19 hospitalization rates in this age group couple...
December 08, 2022 | News
BICO Group is a pioneer and leading provider of instruments and consumables for bioprinting, bioscience and bioautomation applications in the life scienc...
December 08, 2022 | News
The US FDA has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis (NK), a rare degenerative eye diseas...
December 08, 2022 | News
Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up Allows Merck t...
December 07, 2022 | News
The complete manufacturing of BVX-0918 from a cancer patient's ovarian tumor now validates the production protocols that had been in development over the p...
December 02, 2022 | News
Most Read
Bio Jobs
News
Editor Picks